Moffitt Initiates Groundbreaking Clinical Trial with Oncolytic Virus for Non-Small Cell Lung Cancer

Moffitt Cancer Center has launched a pioneering clinical trial for patients with late-stage non-small cell lung cancer whose disease has progressed following in

Related Keywords

Andreas Saltos ,Memgen Inc ,Department Of Immunology At Moffitt ,Department Of Thoracic Oncology At Moffitt ,Moffitt Cancer Center ,Duke Cancer Institute ,National Cancer Institute ,Thoracic Oncology ,National Cancer ,Moffitt Cancer ,